Available Technologies
# of Displayed Technologies: 3 / 3
Applied Category Filter (Click To Remove): Screening Assays
Magnetic Nanoparticles for Cancer Cell Classification
TS-064577 — Glioblastoma (GBM) is the most common malignant brain tumor accounting for 47.7% of all brain cancers. Unfortunately, treatments are limited, and survival is poor, with approximately only 40% living past the first-year post-diagnosis and 17% in the second year.
The Need
Developing drugs for cance…
- College: College of Arts & Sciences
- Inventors: Schultz, Zachary; Rist, David; Skardal, Aleksander; Venere, Monica
- Licensing Officer: Willson, Christopher
Automated Plant DNA Extraction for Portable Genomic Sequencing
TS-063963 — The Need
In the dynamic realm of space exploration, the imperative to sustain life during extended missions places a critical demand on understanding the impact of spaceflight on plant growth. Traditional DNA sequencing methods employed by NASA fall short when dealing with plant material, necessita…
- College: College of Engineering (COE)
- Inventors: Brozovich, Cassidy; Ling, Peter; Tkach, Chris
- Licensing Officer: Panic, Ana
Prognostic Indications of Canine Lymphoid Neoplasia Using Plasma DNA
TS-040419 — A method of identifying a canine lymphoid neoplastic disease with no clinical symptoms using plasma DNA.
Dogs, like humans, are susceptible to development of abnormal growths or cancers. Improved veterinary medical care and diagnostic techniques have enabled a longer lifespan for dogs; however, older populations also have higher incidence rates of canine cancers. This proliferation in incidence of ca…
- College: College of Veterinary Medicine
- Inventors: Rush, Laura; Davuluri, Ramana; Kisseberth, William; Singer, Greg; Sun, Hao
- Licensing Officer: Dahlman, Jason "Jay"
